CYTOSORBENTS CORPORATION Loss Contingency, Estimate of Possible Loss
CYTOSORBENTS CORPORATION (CTSO) had Loss Contingency, Estimate of Possible Loss of $89.00 thousand as of 2021-03-31, per its 10-Q filed 2021-08-03.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2021-08-03
- 2021-03-31: Loss Contingency, Estimate of Possible Loss $89.00K.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2021-03-31 | $89.00K 10-Q · filed 2021-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |